Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Inhibrx Biosciences (INBX) Interest Expenses (2023 - 2025)

Historic Interest Expenses for Inhibrx Biosciences (INBX) over the last 3 years, with Q3 2025 value amounting to $3.2 million.

  • Inhibrx Biosciences' Interest Expenses changed N/A to $3.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.0 million, marking a year-over-year decrease of 5850.14%. This contributed to the annual value of $13.5 million for FY2024, which is 5762.88% down from last year.
  • According to the latest figures from Q3 2025, Inhibrx Biosciences' Interest Expenses is $3.2 million.
  • Over the past 5 years, Inhibrx Biosciences' Interest Expenses peaked at $8.2 million during Q4 2023, and registered a low of $2.7 million during Q1 2025.
  • Its 3-year average for Interest Expenses is $5.8 million, with a median of $6.6 million in 2023.
  • Per our database at Business Quant, Inhibrx Biosciences' Interest Expenses plummeted by 3218.22% in 2024 and then tumbled by 6692.5% in 2025.
  • Over the past 3 years, Inhibrx Biosciences' Interest Expenses (Quarter) stood at $8.2 million in 2023, then crashed by 34.8% to $5.4 million in 2024, then plummeted by 40.66% to $3.2 million in 2025.
  • Its Interest Expenses was $3.2 million in Q3 2025, compared to $3.1 million in Q2 2025 and $2.7 million in Q1 2025.